ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,614Medicare Part D Prescriptions Filled, Including Refills

Rank: 331 out of 1844

$498K Total Retail Price of All Prescriptions

Rank: 360 out of 1844

387 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 6,495 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 413 359 1 3
LEVOTHYROXINE SODIUM 377 308 2 1
HYDROCODONE-ACETAMINOPHEN 355 199 S3 3 2
ZOLPIDEM TARTRATE 261 220 4 23
LISINOPRIL 190 143 5 4
METFORMIN HCL 187 119 6 8
OMEPRAZOLE 179 124 7 5
AMLODIPINE BESYLATE 170 131 8 6
FUROSEMIDE 166 131 9 7
CLONIDINE HCL 144 132 10 64
DICLOFENAC SODIUM 143 108 11 122
TRAMADOL HCL 136 115 12 18
ATENOLOL 114 75 13 17
GABAPENTIN 112 91 14 15
ATORVASTATIN CALCIUM 105 84 15 12
CYMBALTA 103 35 16 36
TAMSULOSIN HCL 103 91 16 27
SYNTHROID 96 88 18 55
TRIAMTERENE-HCTZ 94 91 19 48
METOPROLOL SUCCINATE 94 77 19 14
METOPROLOL TARTRATE 94 90 19 11
HYDROCHLOROTHIAZIDE 93 77 22 9
CITALOPRAM HBR 93 90 22 19
AMOX TR-POTASSIUM CLAVULANATE 89 75 24 139
KLOR-CON 10 82 77 25 123
DIOVAN 81 81 26 58
WARFARIN SODIUM 75 58 27 13
CLOPIDOGREL 74 74 28 34
GEMFIBROZIL 72 53 29 108
SERTRALINE HCL 71 55 30 21
VERAPAMIL ER 69 59 31 98
SPIRONOLACTONE 68 62 32 60
OXYCODONE HCL-ACETAMINOPHEN 64 34 S2 33 83
MELOXICAM 62 47 34 28
GLYBURIDE 57 50 R 35 100
PREDNISONE 55 55 36 40
NEXIUM 53 25 37 31
POTASSIUM CHLORIDE 52 32 38 16
ALENDRONATE SODIUM 52 38 38 25
DONEPEZIL HCL 51 46 40 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.